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ABSTRACT
Objective To compare the effect of home based and
supervised centre based cardiac rehabilitation on
mortality and morbidity, health related quality of life, and
modifiable cardiac risk factors in patients with coronary
heart disease.
Design Systematic review.
Data sources Cochrane Central Register of Controlled
Trials (CENTRAL) in the Cochrane Library, Medline,
Embase, CINAHL, and PsycINFO, without language
restriction, searched from 2001 to January 2008.
Review methods Reference lists checked and advice
sought from authors. Included randomised controlled
trials that compared centre based cardiac rehabilitation
with home based programmes in adults with acute
myocardial infarction, angina, or heart failure or who had
undergone coronary revascularisation. Two reviewers
independently assessed the eligibility of the identified
trials and extracted data independently. Authors were
contacted when possible to obtain missing information.
Results 12 studies (1938 participants) were included.
Most studies recruited patients with a low risk of further
events aftermyocardial infarction or revascularisation. No
difference was seen between home based and centre
based cardiac rehabilitation in terms of mortality (relative
risk 1.31, 95% confidence interval 0.65 to 2.66), cardiac
events, exercise capacity (standardised mean difference
−0.11, −0.35 to 0.13), modifiable risk factors (weighted
mean difference systolic blood pressure (0.58 mm Hg,
−3.29 mm Hg to 4.44 mm Hg), total cholesterol
(−0.13 mmol/l, −0.31 mmol/l to 0.05 mmol/l), low
density lipoprotein cholesterol (−0.15 mmol/l,
−0.31 mmol/l to 0.01 mmol/l), or relative risk for
proportion of smokers at follow-up (0.98, 0.73 to 1.31)),
or health related quality of life, with the exception of high
density lipoprotein cholesterol (−0.06, −0.11 to −0.02)
mmol/l). In the home based participants, there was
evidence of superior adherence. No consistent difference
was seen in the healthcare costs of the two forms of
cardiac rehabilitation.
Conclusions Home and centre based forms of cardiac
rehabilitation seem to be equally effective in improving
clinical and health related quality of life outcomes in
patients with a low risk of further events after myocardial
infarction or revascularisation. This finding, together with
the absence of evidence of differences in patients’
adherence and healthcare costs between the two
approaches, supports the further provision of evidence
based, home based cardiac rehabilitation programmes
such as the “Heart Manual.” The choice of participating in
a more traditional supervised centre based or evidence
based home based programme should reflect the
preference of the individual patient.
INTRODUCTION
Coronary heart disease is a major cause of mortality
and morbidity.1-3 Although mortality from coronary
heart disease has decreased in many developed coun-
tries in recent decades, morbidity is increasing as a
result of improved diagnosis andmore successful treat-
ment of acute illness, which has resulted in an increase
in the number of people who survive myocardial
infarction.1 2 Cardiac rehabilitation is offered to people
after cardiac events to aid recovery and prevent further
cardiac illness. It has been shown to improve physical
health and decrease subsequentmorbidity andmortal-
ity in patients with coronary heart disease (myocardial
infarction and after revascularisation). Two systematic
reviews that included 48 randomised controlled trials
showed a 20% reduction in all cause mortality and a
27% reduction in cardiac mortality at two to five
years.4 5 Cardiac rehabilitation programmes typically
achieve this through exercise, education, behaviour
change, counselling, support, and strategies aimed at
targeting traditional risk factors for cardiovascular dis-
ease. Cardiac rehabilitation is an essential part of the
contemporary care of patients with heart disease and is
considered a priority in countries with a high preva-
lence of coronary heart disease and heart failure.6-10
Although cardiac rehabilitation has been shown to
have beneficial effects, participation remains subopti-
mal. The main reasons people give for not accepting
the invitation to attend centre based cardiac rehabilita-
tion classes—held for groups in hospitals, gyms, or
community leisure centres—are problems with acces-
sibility and parking at their local hospital,11-13 a dislike
of groups,14 and work or domestic commitments.15-18
These problems can be overcome by home based
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programmes, which have been introduced in an
attempt to widen access and participation.19
The one systematic review (of randomised con-
trolled trials) that compared home based and centre
based cardiac rehabilitation to date found no signifi-
cant differences in outcomes,20 but there were only
750 participants in total and patients with heart failure
were excluded. Two large randomised controlled trials
that compared home based and centre based cardiac
rehabilitation in the United Kingdom have recently
been completed.21 22 We determined the effectiveness
of home based cardiac rehabilitation programmes
compared with supervised centre based cardiac reha-
bilitation on mortality, morbidity, health related qual-
ity of life, andmodifiable cardiac risk factors in patients
with coronary heart disease.
METHODS
Criteria for considering studies for this review
Studies included—We included randomised controlled
trials (individual or cluster level).
Types of participants—The study population included
adults with myocardial infarction, angina, or heart fail-
ure and patients who had undergone revascularisation
(coronary artery bypass grafting, percutaneous trans-
luminal coronary angioplasty, or coronary artery
stenting). All had taken part in or been invited to take
part in cardiac rehabilitation. We excluded studies of
participants with heart transplants, cardiac resynchro-
nisation devices, or implantable defibrillators.
Types of interventions—Home based cardiac rehabili-
tation was defined as a structured programme, with
clear objectives for the participants, includingmonitor-
ing, follow-up, visits, letters, telephone calls from staff,
or at least self monitoring diaries. Centre based cardiac
rehabilitation was a supervised group based pro-
grammeundertaken in a hospital or community setting
such as a sports centre.
Types of outcome measures—Outcome measures
included mortality (cardiac and overall), morbidity
(reinfarction, revascularisation, and admission to hos-
pital associated with cardiac disease), exercise capa-
city, modifiable coronary risk factors (smoking
behaviour, blood lipid concentrations, and blood pres-
sure), health related quality of life, adverse events
(withdrawal from the exercise programme), health ser-
vice use or costs, and cost effectiveness. During the
review (and before any data analysis was undertaken),
we agreed to include the outcome of adherence to the
intervention.
Search methods for identification of studies
Weidentified randomisedcontrolled trials fromthepre-
viously published systematic review.20 We updated the
list of studies by searching several clinical databases
from 2001 to January 2008: the Cochrane Central
Register of Controlled Trials (CENTRAL) in the
Cochrane Library, Medline, Embase, CINAHL, and
PsycINFO. We located additional studies in the data-
bases of the NHS Centre for Reviews and Dissemina-
tion (the Health Technology Assessment (HTA)
database and the Database of Abstracts of Reviews of
Effects (DARE)). We searched conference proceedings
on the ISIWebofKnowledge.We identified grey litera-
ture through a web search of major health technology
appraisal agencies. We limited searches to randomised
controlled trials, systematic reviews, and meta-analyses
and imposed no language or other limitations.
Selection of studies—Two reviewers (RST and Phi-
lippa Davies) independently screened the titles and
abstracts of studies identified by the search strategy
and discarded clearly irrelevant studies. To be
selected, abstracts needed to clearly identify the study
design, define an appropriate population, and describe
relevant components of the intervention, as defined
above. The same two reviewers also independently
assessed the full text reports of all potentially relevant
trials and assessed them independently for eligibility
on the basis of the defined inclusion criteria. They
resolved any disagreement by discussion; if any uncer-
tainty remained, they sought the opinion of two further
reviewers (KJ and AZ).
Data extraction andmanagement—Datawere extracted
by a single reviewer (AZ) and checked by a second
reviewer (RST). Standardised data extraction forms
were used to extract relevant data regarding inclusion
criteria (study design, participants, interventions, and
outcomes), risk of bias (randomisation, blinding, attri-
tion, and outcome reporting), and results. In cases for
which insufficient details were reported, AZ contacted
the authors for further information.
Assessment of risk of bias in included studies—The risk of
bias in eligible trials was assessed by a single reviewer
(AZ) and checked by a second reviewer (RST) in accor-
dance with recent guidance.23 The risk of bias was
Titles identified from electronic bibliographies and screened for retrieval (n=11 561)
Potentially appropriate full publications retrieved for full evaluation (n=13)
Randomised controlled trials included in review (n=6) (13 publications)
Found in references (n=4)
Excluded (n=11 548)
Excluded (n=4):
  Home based v home based cardiac rehabilitation (n=1)
  Home based cardiac rehabilitation v usual care (n=2)
  Non-randomised controlled trial (n=1)
Total number of randomised controlled trials included in review (n=12) (21 publications)
Randomised controlled trial included in
Jolly review20 (n=6) (n=8 publications)
Fig 1 | Summary of study selection process
Table 1 | Characteristics of excluded studies
Citation Reason for exclusion
Ades et al,w1 2000 Not randomised controlled trial
Tygssen et al,w2 2001 Both trial arms received home based cardiac rehabilitation
Senuzun et al,w3 2006 Trial arms involved home based cardiac rehabilitation and usual care
Sinclair et al,w4 2005 Trial arms involved home based cardiac rehabilitation and usual care
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assessed in terms of the quality of random sequence
generation and allocation concealment, description of
dropouts and withdrawals, blinding (participants, per-
sonnel, and outcome assessment), and selective out-
come reporting. We determined whether groups
were balanced at baseline and whether an intention
to treat analysis was undertaken.
Data synthesis
We processed data in accordance with the Cochrane
handbook.23 For dichotomous variables, we derived
the relative risks and 95% confidence intervals for
each outcome. For continuous variables, we calculated
the mean differences and 95% confidence intervals for
each outcome. When the results at follow-up and
Table 2 | Summary of included studies
Study Methods
No of
participants Interventions Outcomes Follow-up Subgroup analyses
Country,
setting
Arthur et al,36
2002, Smith et
al,33 2004
RCT parallel
group
242 Home v centre
based
Primary: exercisecapacity (METs).Secondary:
HRQoL (SF-36), cardiac morbidity, mortality
6 and
18months after
randomisation
No subgroups described or
reported
Canada, single
centre
Bell et al,30 1998 RCT parallel
group
252 Home (Heart
Manual) v
centre based
Primary: exercisecapacity (METs).Secondary:
total cholesterol, systolic blood pressure,
HRQoL (NHP), smoking, mortality,
readmission rate, useof primary care services
16 and
48 weeks after
randomisation
(20 and
52 weeks after
myocardial
infarction)
No subgroups described or
reported
UK, five district
hospitals
Carlson et al,32
2000
RCT parallel
group
80 Home v centre
based
Primary: peak functional capacity (METs), LDL
cholesterol. Secondary: total cholesterol,HDL
cholesterol, triglycerides, blood pressure,
cardiovascular medications, costs,
adherence (exercise sessions attended)
6 months after
randomisation
No subgroups described or
reported
US, single
hospital centre
Dalal et al,21
2007, Taylor et
al,31 2007
RCT parallel
group
104 Home (Heart
Manual) v
centre based
Primary: quality of life (MacNew
questionnaire), total cholesterol. Secondary:
exercise capacity (METs), self reported
smoking, cardiovascularmorbidity,mortality,
secondary prevention medication
9 months after
randomisation
No subgroups described or
reported
UK, single centre
Daskapan et
al,34 2005
RCT parallel
group
29 Home v centre
based
Exercise capacity (ml/kg/min)*, resting BP*,
systolic and diastolic BP*, adherence*, drop
outs*
12 weeks after
randomisation
No subgroups described or
reported
Turkey, single
centre
Gordon et al,26
2002
RCT parallel
group
155 Supervised
home v
community
home v centre
based
Maximal oxygen uptake*, blood pressure*,
fasting serum lipids*, self reported smoking
status*, rehospitalisation*, adherence
(completion of appointments)*
12 weeks after
randomisation
Changesreportedforallpatients
and for patients with baseline
values defined as abnormal
US, single centre
Jollyetal,222007 RCT parallel
group
525 Home (Heart
Manual) v
centre based
Primary: serum cholesterol, total cholesterol,
HDL cholesterol, blood pressure, exercise
capacity (ISWT), smoking (validated by
cotinine). Secondary: quality of life (EQ-5D),
SF-12, health service use (hospital
readmissions, primary care visits,
medication), mortality, cardiovascular
events, costs
6, 12, and
24 months
Yes (“interaction terms between
these factors (diagnosis (MI/
revascularisation),
age, sex and ethnicity) and
rehabilitation setting were
included to investigate
possible differences in
treatment effect between
subgroups of patients”)
UK, four hospital
centres
Kassaian et al,25
1998
RCT parallel
group
125 Home v centre
based
Systolic BP*, diastolic BP*, heart rate (all
resting and submaximal)*, functional
capacity (METs)*, BMI*, cholesterol (total,
LDL, HDL, triglycerides)*
12 weeks after
randomisation
Comparison of functional
capacity, submaximal systolic
BP, diastolic BP and
heart rate in patients with left
ventricular dysfunction versus
good left ventricular function
Iran, single
centre
Marchionni et
al,24 2003
RCT parallel
group
180 Home v centre
based
Primary: TWC. Secondary: HRQoL (SIP),
mortality, morbidity (cardiovascular events),
healthcare use (medical visits,
rehospitalisations), costs, adherence
(number of completed training sessions)
2, 8, and
14months after
randomisation
Subgroup analysis by age
(years): middle aged (45-65),
old (65-75), very old (>75)
Italy, single
hospital centre
Miller et al,27
1984, DeBusk et
al,28 1985,
Taylor et al,29
1986
RCT parallel
group
127 Home v centre
based
Exercise capacity*, mortality*, cardiovascular
morbidity*
23 weeks after
randomisation
Results reported according to
two subgroups reported (brief v
extended exercise training)
US, single
hospital centre
Sparks et al,37
1993
RCT parallel
group
20 Home v centre
based
Exercise capacity (peak VO2max), adherence
(compliance with exercise), safety (drop out)
12 weeks after
randomisation
No subgroups described or
reported
US, single
hospital centre
Wu et al,35 2008 RCT parallel
group
36 Home v centre
based
Exercise capacity (METs)* 12 weeks after
randomisation
No subgroups described or
reported
Taiwan (China),
single centre
BMI=body mass index; CR=cardiac rehabilitation; HDL=high density lipoprotein; HRQOL=health-related quality of life; ISWT=incremental shuttle walking test; LDL=low density lipoprotein;
MET=metabolic equivalent; NHP=Nottingham health profile; RCT=randomised controlled trial; SIP=sickness impact profile; TWC=total work capacity; VO2max=maximum volume of oxygen.
*Primary and secondary outcomes not distinguished.
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 3 of 15
Table 3 | Summary of intervention details21 22 24-27 30 32 34-37
Study Home based intervention Centre based intervention
Arthur (2002)36
Exercise Total duration: 6 months, 5 sessions/week, 40 min/session. Intensity: 60-70% of maximum oxygen
intake. Modality: walking. Also attended 1 hour’s exercise consultation with exercise specialist at
baseline and after 3 months of training and completed exercises log that was reviewed every 2 months
and telephone support call every 2 weeks
Total duration: 6 months, 3 sessions/week, 40min/session. Intensity: 60-
70% of maximum oxygen intake. Modality: cycle ergometer, treadmill,
track walking and stair climbing. Supervised by exercise specialist and
completed exercises log, reviewed every month
Other Dietary advice and psychological support Dietary advice and psychological support
Bell (1998)30 Heart Manual
Exercise Overall duration: 6 weeks. Frequency, duration, and intensity: NR Overall duration and frequency: 12 weeks of 1 session/week or 4 weeks of
2 sessions/week, ≥20 min/session. Intensity: 3-4 on Borg rating of
perceived exertion (RPE) scale
Other Four phone calls by facilitator, health education, and stress management Education sessions: causes of coronary heart disease, medication, risk
factor modification, stress management, exercise
Carlson (2000)32
Exercise Overall duration: 25 weeks, 2-5 sessions/week, 30-40 min/session. Intensity: 60-85% of aerobic
capacity. Modality: aerobic exercise; for first 4 weeks, 3 hospital based exercise sessions/week with
electrocardiographic monitoring and then progressive reduction in frequency of centre based sessions
Overall duration: 25 weeks, 2-3 sessions/week, 30-45 min/session.
Intensity: 60-85% of aerobic capacity. Modality: aerobic exercise
Other Weekly educational and counselling meetings included sessions on exercise, diet, risk factors, drugs,
and overcoming barriers to behaviour change. Based on Bandura’s self efficacy theory
Three sessions of education and counselling that included sessions on
exercise, diet, risk factors, and drugs
Dalal (2007)21 Heart Manual
Exercise Overall duration: 6 weeks. Frequency, duration, and intensity: NR. Modality: walking. Home visit in first
week after discharge by cardiac rehabilitation nurse followed by up to 4 telephone calls at 2, 3, 4, and
6 weeks
Overall duration: 8-10 weeks, 1-5 sessions/week. Duration and modality:
NR. Supervised and group based
Other Stress management and education Input from dietician, psychologist, occupational therapist and pharmacist
Daskapan (2007)34
Exercise Total duration: 12 weeks, 3 sessions/week, 45 min/session (including warm up, cool down, and
recovery). Intensity: up to 60% of peak heart rate (12-16 on Borg rating of perceived exertion (RPE) scale).
Modality: walking. Follow-up logs completed daily/returned biweekly. Weekly phone calls from staff to
monitor adherence and progress. Monthly phone calls from patients for control purposes
Total duration: 12 weeks, 3 sessions/week, 45 min/session (including
warm up, cool down, and recovery). Intensity: 60% of peak heart rate.
Modality: walking on a treadmill. Supervised
Other NR NR
Gordon (2002)26
Exercise Group I (supervised home based cardiac rehabilitation): total duration: 12 weeks. Intensity: individually
prescribed (30-60 min of aerobic exercise at 60-85% of peak heart rate) gradually updated;
appointments: two office visits and four phone calls. Group II (community home based cardiac
rehabilitation): total duration: 12 weeks, individually prescribed (30-60 minutes of aerobic exercise at
60-85% of peak heart rate), gradually updated. Appointments: 12 onsite visits or telephone calls (patient
choice)
Total duration: 12 weeks, 3/sessions/week (total of 36 sessions and
appointments). Intensity: individually prescribed (30-60 minutes of
aerobic exercise at 60-85% of peak heart rate). Continuous
electrocardiographic telemetry during exercise
Other Group I and group II: written materials, audiotapes, nutrition, weight and stress management, smoking
cessation programme, individual management of risk factors for coronary artery disease
Written materials, audiotapes, education on risk factors for coronary artery
disease, and lifestyle modification
Jolly (2007)22 Heart Manual/Centre based cardiac rehabilitation (control)
Exercise Overall duration: six weeks of Heart Manual’s programme and 12 weeks of nurse support. Frequency: up
to daily. Duration and intensity: NR. Modality: walking
Total duration: 6-12 weeks, 1-2 sessions/week, 25-30 min/session.
Intensity: 65-75% of maximum heart rate. Modality: circuit training, cycle
ergometer
Other Education about risk factors, lifestyle changes, medications and stress management (relaxation tapes) Education and stress management (relaxation)
Kassaian (2000)25
Exercise Total duration: 12 weeks. Frequency and duration: NR. Intensity: “intensity based on exercise test results” Total duration: 12 weeks, 3 sessions/week, 20-30 min, 10 min warm up,
and 10 min cool-down/session. Intensity: 60-85% (NR if relative to
maximum heart rate or maximum oxygen intake). Modality: treadmill
Other Patients taught to count their pulse rate NR
Marchionni (2003)24
Exercise Overall duration: 8 weeks, 3 days/week, 1 h/session. Intensity: 70-85% of peak heart rate. Modality:
cycle ergometer. Physical therapist home visits every other week
Overall duration: programme of 12 weeks, 3 days/week. Duration: NR.
Intensity 70-85% of peak heart rate. Modality: cycle ergometer. Trans-
telephonic electrocardiographic monitoring during exercise
Other Monthly family oriented support groups Risk factor management counselling; support group meetings
Miller (1984)27
Exercise Overall duration: 8 weeks, 3 days/week, 1 h/session. Intensity: 70-85% of peak heart rate. Modality:
cycle ergometer. Physical therapist home visits every other week
Overall duration: 8weeks (brief) or 23weeks (extended), 5 sessions/week,
60 min/session. Intensity: 70-85% of maximum heart rate. Modality:
walking/jogging. Group based and supervised
Other Monthly family oriented support groups No education or psychological intervention reported
Sparks (1993)37
Exercise Overall duration: 12 weeks, 3 days/week, 1 h/session. Intensity 60-75% of peak heart rate. Modality:
cycle ergometer. Trans-telephonic electrocardiographic monitoring
Overall duration: 12weeks, 3 days/week, 1 h/session. Intensity 60-75%of
peak heart rate. Modality: cycle ergometer. No trans-telephonic
electrocardiographic monitoring
Other Education materials on diet, medications, and risks and benefits of exercise Education materials on diet, medications, and risks and benefits of the
exercise
Wu (2006)35
Exercise Total duration: 12 weeks, ≥3 sessions/week, 30-60 min + 10 min warm up + 10 min cool-down/session.
Intensity: 60-85% of maximum heart rate. Modality: fast walking or jogging. Exercise documented in
record book. Prescription of exercise individually given and updated every two weeks by rehabilitation
nurse
Total duration: 12 weeks, 3 sessions/week (total 36 sessions), 30-60 min
+ 10 minute warm up + 10 minute cool-down/session. Intensity: 60-85%
of maximum heart rate. Modality: cycle ergometer, treadmill. Exercise
supervised by cardiopulmonary physical therapist
Other NR NR
NR=not reported.
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differences between groups for each of the individual
trials were not reported in the original publications, we
calculated P values for the differences.23
We explored heterogeneity among the included stu-
dies qualitatively (by comparing the characteristics of
included studies) and quantitatively (using the χ2 test of
heterogeneity and I2 statistic). When appropriate, we
combined the results from included studies for each
outcome to give an overall estimate of the treatment
effect. We used a fixed effect model for meta-analysis,
except where we identified statistical heterogeneity,
when we used a random effects model instead. In the
protocol for this review, we intended to use meta-
regression to explore heterogeneity and examine
potential treatment effect modifiers. Given the small
number of included trials, however, such analyses
were deemed inappropriately underpowered. Instead,
we undertook specific stratified meta-analyses to
examine the sensitivity of the findings of the review
to key potential causes of heterogeneity. Continuous
outcomes were pooled as a weighted mean difference
except for the exercise capacity measures, which we
expressed as a standardised mean difference because
of the variety of measures. In the study that reported
continuous outcome findings by three age subcate-
gories, we pooled results to produce a single omnibus
score for each group.24
We used sensitivity analysis to examine two areas of
uncertainty. Firstly, for exercise capacity, in addition to
pooling all trialswith standardisedmeandifference,we
pooledmost trials that reported outcomes asmetabolic
equivalents usingweightedmeandifference. Secondly,
the lack of detailed reporting meant that there was
some doubt about whether or not the study by Kas-
saian et al was a true comparison between home
based and hospital based cardiac rehabilitation or
was, instead, a comparison of hospital based cardiac
rehabilitation and usual care.25 We undertook all
meta-analyses with and without this trial.
Gordon et al compared two home based exercise
programmes with a centre based cardiac rehabilitation
programme26 and Miller et al reported results in
subgroups by the duration of intervention.27-29 For
these two studies, we included outcome results in the
meta-analysis separately for the two home based
groups and for the short and long duration exercise
groups, respectively.
RESULTS
Description of studies
Search results—The systematic reviewby Jolly et al iden-
tified six trials (eight papers),20 all of which met the
inclusion criteria of this review. Our updated electro-
nic searches yielded a total of 11 561 titles. After we
reviewed the titles and abstracts, we retrieved an addi-
tional 13 full papers for possible inclusion and identi-
fied a further four from the reference lists of eligible
publications. We excluded four papers (see
bmj.com). In total, we included 21 papers that reported
on 12 studies. Figure 1 summarises the study selection
process, and table 1 gives details of the excluded stu-
dies and reasons for their exclusion.
Included studies—Three studies were based in the
UK,21 22 30 31 four in the United States.26-29 32 and one
each in Canada,33 34 Turkey,35 Italy,24 Iran,4 and
China36 (table 2). Most studies reported outcomes up
to 12 months after randomisation; only three reported
longer follow-up of 24 months,22 14 months,24 and
18 months.33 34 Eight studies compared comprehen-
sive programmes (that is, exercise plus education or
psychological management, or both), while the
remainder reported only on an exercise inter
vention.25 27-29 35-37 The cardiac rehabilitation pro-
grammes differed considerably in duration (range 1.
5-6 months), frequency (1-5 sessions/week), and ses-
sion length (20-60 minutes/session). Most pro-
grammes involved the prescription of individually
tailored exercise programmes, which makes it difficult
to precisely quantify the amount of exercise underta-
ken. Several home based programmes included a short
initial period of centre based intervention.26 32 34Centre
basedprogrammes typically involved supervised exer-
cise involving cycles and treadmills, while virtually all
home based programmes were based on walking, with
Table 4 | Summary of risk of bias assessment
Study
Adequate sequence
generation
Allocation
concealment
Outcome
blinding
Incomplete outcome
data addressed
Intention to treat
analysis
Arthur (2002)36 Unclear Yes Yes Yes (dropout rate: 8% and 10% at 6
and 18 months, respectively)
Yes
Bell (1998)30 Unclear Yes Yes Unclear No
Carlson (2000)32 Unclear Unclear Unclear No Yes
Dalal (2007)21 Yes Yes Yes Yes Yes
Daskapan (2007)34 Unclear Unclear Unclear Yes No
Gordon (2002)26 Unclear Unclear Unclear Yes Unclear
Jolly (2007)22 Yes Yes Yes Yes Yes
Kassaian (2000)25 Unclear Unclear Unclear Unclear Unclear
Marchionni (2003)24 Unclear Unclear Yes Yes Yes
Miller (1984)27 Unclear Unclear Unclear Yes Yes
Sparks (1993)37 Unclear Unclear Unclear Yes Yes
Wu (2006)35 Unclear Unclear Yes Unclear Unclear
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some level of intermittent telephone support from a
nurse or exercise specialist (table 3). Most studies
recruited patients at low risk of another event after
acute myocardial infarction or revascularisation,
excluding those with severe arrhythmias, ischaemia,
or heart failure. Two studies included patients with
New York Heart Association class 2 or 3 heart
failure. 25 35
Risk of bias in included studies
Several studies failed to give enough detail for us to
assess the potential risk of bias. Details of the genera-
tion and concealment of the random allocation
sequence was particularly poorly reported. Only one
study presented objective evidence of an imbalance in
baseline characteristics.33 34 Only six studies stated that
they took measures to blind those involved in assess-
ments. Losses to follow-up varied considerably and
were often asymmetric across the homebased and cen-
tre based cardiac rehabilitation groups. Although the
type of analysis was often not stated, all studies seemed
to undertake an intention to treat analysis, in that
groups were analysed according to the initial random
allocation. Only a few trials examined the impact of
losses to follow-up or drop out. As discussed above,
the rehabilitation intervention was usually tailored to
the individual patient, so it is difficult to quantify the
precise level of intervention; however, the intensity of
the rehabilitation programme seemed to differ sub-
stantially between the home based and centre based
arms. Table 4 gives a summary of the assessment of
risk of bias for each included study.
Effects of interventions on exercise capacity
All 12 included trials reported exercise capacity in the
short term (3-12 months of follow-up), while
Table 5 | Summary of effects of home based versus centre based cardiac rehabilitation21 22 24-36
Outcome or subgroup
No of
studies
No of
participants Summary estimate and model
Effect estimate
(95% CI)
Heterogeneity
χ2 df P value I2 (%)
Exercise capacity:
At 3-12 month follow-up 14 1938 Standard mean difference, random effects model −0.11 (−0.35 to 0.13) 60.91 13 <0.001 79
At 12-24 month follow-up 4 1074 Standard mean difference, fixed effects model 0.11 (−0.01 to 0.23) 0.87 3 0.62 0
Blood pressure (mm Hg) at 3-12 month follow-up:
Systolic 9 1053 Mean difference, random effects model −0.51 (−4.63 to 3.61) 23.01 7 0.002 70
Diastolic 7 927 Mean difference, random effects model 1.85 (0.74 to 2.96) 7.97 6 0.24 25
Cholesterol (mmol/l) at 3-12 month follow-up:
Total 7 1019 Mean difference, random effects model 0.13 (−0.05 to 0.31) 13.33 6 0.04 55
High density lipoprotein 5 793 Mean difference, fixed effects model −0.06(−0.11to−0.02) 4.44 3 0.22 32
Low density lipoprotein 4 324 Mean difference, fixed effects model 0.15 (−0.01 to 0.31) 6.53 4 0.16 39
Triglycerides 4 328 Mean difference, random effects model 0.15 (−0.11 to 0.41) 7.58 3 0.06 60
Smoking 5 922 Relative risk, fixed effects model 1.02 (0.76 to 1.37) 4.48 4 0.34 11
Completers 10 1714 Risk ratio, fixed effects model 1.00 (0.97 to 1.04) 11.4 10 0.32 13
Mortality 4 909 Relative risk, fixed effects model 1.31 (0.65 to 2.66) 1.00 3 0.80 0
0.00 (-0.26 to 0.27)
0.06 (-0.23 to 0.35)
0.37 (-0.13 to 0.87)
0.66 (0.26 to 1.06)
0.04 (-0.80 to 0.88)
0.00 (-0.52 to 0.52)
-0.35 (-0.86 to 0.15)
-0.10 (-0.30 to 0.10)
-1.24 (-1.63 to -0.86)
0.04 (-0.28 to 0.36)
0.07 (-0.42 to 0.56)
-0.68 (-1.19 to -0.17)
-0.16 (-1.04 to 0.72)
-0.32 (-0.97 to 0.34)
-0.11 (-0.35 to 0.13)
8.9
8.7
6.9
7.8
4.5
6.8
6.9
9.3
7.9
8.5
7.0
6.9
4.2
5.7
100.0
-2 -1 0 1 2
Favours centre
based CR
Favours home
based CR
Standard
mean difference
(random 95% CI)
Standard
mean difference
(random 95% CI)
Weight
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  Jolly 200722
  Kassaian 200025
  Marchionni 200324
  Miller 1984 (brief)27
  Miller 1984 (expanded)27
  Sparks 199337
  Wu 200635
Total (95% CI)
Test for heterogeneity: τ2=0.15, χ2=60.91, df=13, P<0.001, I2=79%
Test for overall effect: z=0.91, P=0.36
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Fig 2 | Exercise capacity with home based and centre based cardiac rehabilitation (CR) at 3-12 months of follow-up
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three22 24 33 34 presented longer term data. Nine studies
reported exercise capacity as the maximum oxygen
intake,37 Jolly et al reported incremental shuttle walk-
ing distance,22 Marchionni et al reported total cycle
work capacity,24 and Gordon et al reported data on
change from baseline only as metabolic equivalents.26
The pooled analysis across all studies showed no evi-
dence of a significant difference in short term exercise
capacity between the home based and centre based
cardiac rehabilitation groups (table 5 and fig 2). Evi-
dence showed substantial heterogeneity, but the find-
ings were the same when we limited pooling to the
eight trials that reportedmaximumoxygen intake (ran-
dom effects weighted mean difference −0.30 (−1.22 to
0.63), heterogeneity χ2=62.12, df=13, P<0.001,
I2=79%). In a pooled analysis of the three studies that
reported longer term data (14-24 months), 22 24 33 34
some evidence indicated that exercise capacity with
home based rehabilitation was better (albeit not signif-
icantly) than with centre based rehabilitation (fixed
effects standardised mean difference 0.11 (−0.01 to
0.23), heterogeneity χ2=0.97, df=2, P=0.62, I2=0%).
Modifiable risk factors
Blood pressure—Seven of the included trials reported on
systolic and diastolic blood pressure21 22 25 26 32 35 or sys-
tolic blood pressure alone.30Outcome at follow-upwas
reported in all but one study,26 which instead reported
change from baseline. We obtained unpublished fol-
low-up data for the study by Dalal et al from the
authors.21 Although no difference in pooled systolic
blood pressure was found between the groups at fol-
low-up of 3-12 months (fig 3), diastolic blood pressure
at follow-up was slightly higher for home based than
for centre based cardiac rehabilitation (fixed effects
weighted mean difference 1.85 (0.74 to 2.96) mm Hg,
heterogeneity χ2=7.97, df=6, P=0.24, I2=25%) (fig 4). At
24months’ follow-up, Jolly et al reportedno significant
difference in systolic blood pressure between the home
and centre based cardiac rehabilitation groups.22
Blood lipids—Six of the included trials reported data
on blood lipids.212225263032 All six reported total choles-
terol values, four reported high density lipoprotein cho-
lesterol concentrations,22252632 and three reported low
density lipoprotein cholesterol and triglyceride
concentrations.252632 High levels of heterogeneity were
seen with total cholesterol. Figures 5-8 summarise the
results. The pooled analysis of data at 3-12 months of
follow-up found no evidence of differences in total cho-
lesterol, low density lipoprotein cholesterol, or trigly-
cerides at follow-up but concentrations of high density
lipoprotein cholesterol were higher with centre based
compared with home based rehabilitation (fixed effects
weightedmeandifference−0.06 (−0.11 to−0.02)mmol/
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1.60 (-6.07 to 9.27)
1.80 (-17.83 to 21.43)
2.00 (-4.17 to 8.17)
0.90 (-4.22 to 6.02)
-1.37 (-5.00 to 2.26)
-7.00 (-10.54 to -3.46)
0.58 (-3.29  to 4.44)
11.8
10.7
11.3
3.3
13.4
15.0
17.2
17.4
100.0
-20 -10 0 10 20
Favours centre
based CR
Favours home
based CR
Mean difference
(random 95% CI)
Mean difference
(random 95% CI)
Weight
(%)
137.2 (20.9)
137 (16)
135.4 (22)
142.7 (21.4)
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Fig 3 | Systolic blood pressure with home based and centre based cardiac rehabilitation at 3-12 months of follow-up
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Fig 4 | Diastolic blood pressure with home based and centre based cardiac rehabilitation (CR) at 3-12 months of follow-up
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l, heterogeneity χ2=6.53, df=4, P=0.16, I2=39%). Jolly et
al reported no significant difference between home
based and centre based cardiac rehabilitation in terms
of total cholesterol or high density lipoprotein choles-
terol at follow-up of 24 months.22
Smoking behaviour—Four studies reported on
patients’ self reported smoking behaviour at
3-12 months of follow-up.21 22 26 30 32 No evidence indi-
cated a difference in the proportion of smokers at fol-
low-up between centre based and home based cardiac
rehabilitation (table 5 and fig 9). Jolly et al reported no
difference in smoking between home based and centre
based arms at 24 months.22
Health related quality of life—Five of the trials reported
validated measures of health related quality of life
(table 6): five generic instruments (EQ-5D, Notting-
ham health profile, SF-36, SF-12, and sickness impact
profile) and one disease specific instrument (MacNew).
Thewide variation in health related quality of lifemea-
suresmeant that pooling across studieswas inappropri-
ate. Overall, there were no significant differences in
overall health related quality of life outcomes or
domain scores at follow-up between home based and
centre based cardiac rehabilitation. The two excep-
tions were a higher score for the sleep domain of the
Nottingham health profile with hospital based cardiac
rehabilitation than home based rehabilitation in the
study by Bell et al30 and a higher score for the physical
component of the SF-36 with home based than centre
based cardiac rehabilitation at six months in the study
by Arthur et al. 33 34
Clinical events
Mortality—Five trials reported all cause mortality up to
one year of follow-up.21 22 27-30 32Miller et al reported no
deaths over the period of the study.27 A pooled analysis
of the remaining studies found no evidence of a signifi-
cant difference in mortality at 3-12 months’ follow-up
between home based and centre based rehabilitation
(fig 10). Jolly et al reported no difference in mortality
between the groups at 24 months of follow up.22
Cardiac events—Only two studies reported cardiac
events during the exercise programme: Dalal et al21
(coronary artery bypass graft and percutaneous trans-
luminal coronary angiography) and Jolly22 (myo-
cardial infarction and revascularisation at 12 months
and 24 months of follow-up). No significant difference
was found between the home based and centre based
programmes.
Withdrawals and adherence
Dropout rates from the intervention were inconsis-
tently reported, and the reasons were often unclear.
Using the number of completers—that is, the number
of patients with outcome data at follow-up—we found
no difference between home based and centre based
programmes (fixed effect relative risk 1.00 (0.97 to
1.04), heterogeneity χ2=11.44, df=10, P=0.32, I2=13%)
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Fig 5 | Total cholesterol (mmol/l) with home based and centre based cardiac rehabilitation at 3-12 months of follow-up
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Fig 6 | High density lipoprotein cholesterol (mmol/l) with home based and centre based cardiac rehabilitation at 3-12 months
of follow-up
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(fig 11). Nine of the trials reported adherence to the
cardiac rehabilitation intervention over the duration
of the study. Substantial variations in the way in
which adherence was defined and measured were
seen, and some studies reported more than one mea-
sure of adherence. Pooling across studies was therefore
deemed inappropriate. Table 7 summarises the find-
ings related to adherence for each individual trial. Two
studies found no evidence of a significant difference in
the level of adherence between the groups, while there
was evidence of a trend towards higher adherence in
the studies of Carlson et al and Jolly et al. 22 32 Adher-
ence was significantly superior (P≤0.05) with home
based cardiac rehabilitation in the studies by Arthur
et al andMarchionni et al. 24 33 34 No study reported sig-
nificantly higher adherence with centre based than
home based rehabilitation. Figure 11 shows a meta-
analysis based on the number of participants with out-
come data at follow-up, who we have deemed to be
completers.
Costs and healthcare use
Four studies reported costs (table 8). Differences in
currencies and the timing of studies means that it was
not possible to compare the costs directly across stu-
dies. In three of the four studies21 24 31 32 the healthcare
costs associated with cardiac rehabilitation were lower
for the home based than the centre based programmes,
although in only one was the cost significantly
lower.21 32 Jolly et al found that home cardiac rehabili-
tation was more expensive than centre based rehabili-
tation, although the costs of the two would be the same
if patients’ costs were included.22
Six studies reported different aspects of consump-
tion of healthcare resources, including readmissions
to hospital, primary care consultations, and use of sec-
ondary care medication (table 9). No significant
between group differences were seen.
Sensitivity analyses
When we removed data from the study by Kassaian et
al25 from the analyses, the only difference in findings
was that the difference between groups in diastolic
blood pressure was not significant. Conclusions were
also the samewhenwe limited analyses to those studies
with comprehensive programmes, except that there
was no longer evidence of differences in diastolic
blood pressure (fixed effects weightedmean difference
0.89 (−0.45 to 2.23) mm Hg, heterogeneity χ2=1.55,
df=4, P=0.82, I2=0%) and high density lipoprotein cho-
lesterol (−0.02 (−0.08 to 0.04) mmol/l, heterogeneity
χ2=0.53, df=3, P=0.91, I2=0%).
DISCUSSION
In this systematic review we assessed the evidence
from randomised controlled trials that compared out-
comeswith home based and centre based cardiac reha-
bilitation. We found no evidence of a difference in
outcomes in patientswith stable coronary heart disease
who received home based or centre based cardiac
rehabilitation in the short term (3-12months) or longer
term (up to 24 months). Outcomes considered
included exercise capacity, modifiable risk factors
(blood pressure, concentrations of lipids in blood,
and smoking), health related quality of life, and cardiac
events (including mortality, revascularisation, and
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Fig 7 | Low density lipoprotein cholesterol (mmol/l) with home based and centre based cardiac rehabilitation at 3-12 months of
follow-up
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Fig 8 | Triglycerides (mmol/l) with home based and centre based cardiac rehabilitation at 3-12 months of follow-up
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readmission to hospital). Healthcare costs seem to
depend on the healthcare economy in which cardiac
rehabilitation is provided; however, we found no con-
sistent evidence to support an important difference in
the healthcare costs associated with home based and
centre based programmes. Evidence supported super-
ior adherence and completion of rehabilitation by
home based users. This is further supported by a
recently published audit from one centre in Cornwall,
which reported better adherence for home based reha-
bilitation (87%) than hospital based classes (49%).19
Our findings are consistent with a recent systematic
review by Jolly et al,20 though our review substantially
increases the body of evidence that compares home
based and centre based cardiac rehabilitation. We
identified 12 randomised controlled trials in 1938
patients with cardiac disease compared with the pre-
vious six trials in 749 patients. The review by Jolly et
al was critical of the variety of home based cardiac
rehabilitation interventions and the small size and
poor quality of trials.20 Since publication of that
review,20 data from two relatively large and high qual-
ity randomised controlled trials (funded by the NHS)
in the UK have been published.21 22 31 The model of
home based provision in the largest three of the
included trials21 22 30 was the “Heart Manual”—a home
based cardiac rehabilitation programme that consists
of a self help manual supported by a facilitator
(fig 12).38 This is the only validated home based pro-
gramme that is recommendedby theNational Institute
for Health and Clinical Excellence in the UK as an
alternative to centre based programmes for patients
after myocardial infarction.8
The mainstay approach to delivery of cardiac reha-
bilitation inmany countries involves inpatient and out-
patient hospital based provision. In North America,
cardiac rehabilitation often takes place in a supervised
university or community setting. The availability of
home based programmes provides an opportunity to
widen access to and participation in cardiac rehabilita-
tion and thereby to improve uptake and adherence.
Furthermore, home based cardiac rehabilitation
might be a less costly alternative for healthcare econo-
mies than the more traditional hospital based
approach. Data from the UK, however, suggest that
only about 20% of cardiac rehabilitation programmes
Table 6 | Summary of health related quality of life (HRQoL) scores at follow-up for home
based and centre based rehabilitation
Measure of HRQoL
Mean (SD) outcome
values at follow-up
P value
Difference
between
groups*Home Centre
Bell et al,30 1998 at 10.5 month follow-up
Nottingham health profile:
Energy 18.6 (28.4) 17.3 (30.7) 0.78† Home = centre
Pain 6.6 (15.3) 7.4 (15.5) 0.74† Home = centre
Emotional reactions 6.6 (15.3) 7.4 (15.5) 0.74† Home = centre
Sleep 6.6 (15.3) 16.9 (22.8) 0.0007† Home < centre
Social isolation 3.7 (13.6) 6.7 (15.0) 0.18† Home = centre
Physical mobility 6.9 (13.5) 9.1 (15.9) 0.33† Home = centre
Arthur et al,36 2002, Smith et al,33 2004
At 6 month follow-up:
SF-36 51.2 (6.4) 48.6 (7.1) 0.003† Home > centre
PCS
MCS 53.5 (6.4) 52.0 (8.1) 0.13† Home = centre
At 18 month follow-up:
SF-36
PCS 48.3 (11.7) 47.6 (11.7) 0.67† Home = centre
MCS 53.0 (10.9) 50.2 (10.9) 0.07† Home = centre
Marchionni et al,31 2003
SIP at 2 month follow-up 2.83 (14.5) 4.71 (11.1) 0.09† Home = centre
SIP at 8 month follow-up 2.83 (14.5) 3.40 (11.1) 0.61† Home = centre
SIP at 14 month follow-up 2.00 (8.3) 3.70 (11.8) 0.06† Home = centre
Dalal et al,21 2007, Taylor et al,31 2007
At 9 month follow-up:
MacNew global score 5.61 (1.14) 5.54 (1.10) 0.71 Home = centre
EQ-5D 0.74 (0.04) 0.78 (0.04) 0.57 Home = centre
Jolly et al,22 2007
At 6 month follow-up:
EQ-5D 0.74 (0.26) 0.76 (0.23) 0.37 Home = centre
SF-12
PCS 42.28 (10.9) 42.56 (10.8) 0.8 Home = centre
MCS 49.19 (10.1) 50.33 (9.6) 0.3 Home = centre
EQ-5D at 12 month follow-up 0.74 (0.27) 0.76 (0.23) 0.52† Home = centre
EQ-5D at 24 month follow-up 0.73 (0.29) 0.75 (0.26) 0.39† Home = centre
MCS=mental component score; PCS=physical component score; SF-12=short form 12 item survey; SF-36=short
form 36 item survey; SIP=sickness impact profile.
*Home = centre: no significant difference (P>0.05) in HRQoL (health related quality of life) between home and
centre based groups at follow-up; home > centre: significant (P≤0.05) higher HRQoL in home v centre based
groups at follow-up; home < centre: significant (P≤0.05) lower HRQoL in home v centre based groups at follow-
up.
†Calculated by authors of this report based on independent two group t test.
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Fig 9 | Relative risk of smoking with home based and centre based cardiac rehabilitation at 3-12 months of follow-up
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currently offer an evidence based, home based option
(EnglishCardiacNetwork survey 2008, Jane Flint, per-
sonal communication).
Our review has limitations. The recruitment of the
included trials was largely limited to patients with
stable coronary heart disease after acute myocardial
infarction or revascularisation, with few patients with
heart failure included. Although most patients in this
review were exposed to the Heart Manual model of
home based cardiac rehabilitation, evidence showed
considerable statistical heterogeneity for several out-
comes across the trials. This heterogeneity reflects the
variety of centre based cardiac rehabilitation inter-
ventions, differences in recruitment and characteristics
of patients, and variation in someoutcome assessments
(such as exercise capacity) across studies.Nevertheless,
it is reassuring that our findings were generally consis-
tent across various sensitivity analyses undertaken to
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Fig 10 | Mortality with home based and centre based cardiac rehabilitation at 3-12 months of follow-up
Table 7 | Summary of adherence at follow-up in home and centre based settings with method for or definition of assessment of adherence*
Findings Difference between
groups†Home Centre P value
Miller et al,27 1984, DeBusk et al,28 1985, Taylor et al,29 1986:
Ratio (%) of exercise session completed v prescribed at 6 months 50:70 (72) 28:40 (71) NA Home = centre‡
Sparks et al,37 1993:
Sessions attended (%) at 3 months 93 88 NA Unclear
Carlson et al,32 2000:
No (%) of patients who attended all three classes on nutrition and risk factors at 6 months 27/38 (71) 33/42 (79) 0.438§ Home = centre
Total exercise over follow-up (No (SD) of sessions ≥30 minutes) at 6 months 111.8 (29.1) 98.1 (33.4) 0.06¶ Home = centre
Gordon et al,26 2002
Completed scheduled appointments (exercise sessions, office/on site visits,
“telephone visits” in accordance with intervention protocol) (%) at 3 months
83 supervised by doctor;
86 community based
81 — Home = centre‡
Arthur et al,36 2002, Smith et al,33 2004:
Mean (SD) No of exercise session reported/week at 6 months 6.5 (4.6) 3.7 (2.6) 0.0001¶ Home > centre
Patients seeking dietician consultation (%) (No (SD) of visits) at 6 months 50 (3.5 (2.5)) 53 (3.6 (2.3)) — Unclear
Patients seeking psychologist consultation (%) (No (SD) of visits) at 18 months 42 (2.6 (2.4)) 51 (2.5 (2.2)) — Home = centre‡
Mean (SD) level of physical activity (PASE) at 18 months 232.6 (99.4) 170.0 (89.2) 0.0001¶ Home > centre
Marchionni et al,24 2003:
No (SD) of exercise sessions completed at 4 months 37.3 (3.4) 34.3 (4.4) <0.0001¶ Home > centre
Daskapan et al,34 2005:
Percentage of sessions attended at 3 months 97 81 NA Unclear
Dalal et al,21 2007:
No (%) who participated in intervention at 9 months 40/60 (67) 32/44 (72) 0.51§ Home = centre
Jolly et al,22 2007:
Hours (SD) of self reported activity weighted for intensity at:
3 months 23.2 (22.1) 18.7 (19.3) 0.06¶ Home = centre
6 months 16.4 (17.0) 18.1 (25.4) 0.4¶ Home = centre
12 months 19.2 (20.8) 15.9 (16.7) 0.06¶ Home = centre
24 months 18.9 (18.4) 16.6 (16.4) 0.16¶ Home = centre
NA=not available; could not be calculated.
*Not reported for Bell et al,30 1998, Kassaian et al,25 1998, and Wu et al,35 2008.
†Home = centre: no significant difference (P>0.05) in HRQoL between home and centre based groups at follow-up; home > centre: significant (P≤0.05) higher HRQoL in home v centre based
groups at follow-up; home < centre: significant (P≤0.05) lower HRQoL in home v centre based groups at follow-up; PASE=physical activity scale for elderly; unclear=home and centre based
groups at follow-up seem different but P value not reported or calculable.
‡Home and centre based groups at follow-up seem to be similar but P value not reported or calculable.
§Calculated by authors of this report based on χ2 test.
¶Calculated by authors of this report based on independent t test.
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explore this heterogeneity. Trials were pooled with a
randomeffectsmodel formeta-analysis in the presence
of statistical heterogeneity. Most studies were of rela-
tively short duration, with only one trial reporting out-
comes at 24 months.22
Patients’ preference has been hypothesised to have
an impact on uptake and adherence to home based
cardiac rehabilitation, and evidence suggests that
white patients who work full time or part time and
feel they have limited time are more likely to have a
preference for home based cardiac rehabilitation.39
Such a hypothesis is difficult to test in a traditional ran-
domised controlled trial so our finding of similar
adherence between home based and centre based
approaches needs to be interpreted with caution. The
trial byDalal et al (Cornwall heart attack rehabilitation
management study (CHARMS)21) used a comprehen-
sive cohort design, which incorporated an element of
preference—by which patients could choose between
home based and hospital based cardiac rehabilitation
—in addition to the randomised element of home
based and centre based allocation. The authors
reported that all of the primary and secondary out-
comes were similar between the home and hospital
preference arms and the randomised comparison.
Adherence to home based cardiac rehabilitation was
also comparable between the randomised (75%) and
preference arms (73%). This finding does not support
Table 8 | Summary of costs in home and centre based settings. Figures are means (SD or 95% confidence interval)
Variable
Carlson
et al,32 2000
Marchionni
et al,24 2003
Dalal et al,21 2007;
Taylor et al,312007 Jolly et al,22 2007
Follow-up (months) 6 14 9 24
Year of costs NR 2000 2002-3 2003
Mean cost of cardiac rehabilitation programme (per patient):
Home $1519 $1650 £170 (8) £198 (189 to 209)
Hospital $2349 $8841 £200 (3) £157 (139 to 175)
Mean (95% CI) difference — — £30 (–45 to –12) —
P value — — 0.001 0.05
Costs considered Staff, ECG,
monitoring
NR Staff, exercise equipment, staff travel Staff, telephone consultations, staff travel
Mean total healthcare costs (per patient):
Home NR $21 298 £3279 (374) NR
Hospital NR $13 246 £3201 (443) NR
Mean (95% CI) difference — — £78 (–1103 to 1191) —
P value — — 0.894 —
Additional healthcare costs considered — NR Readmissions, revascularisations, secondary
preventive medication, investigations, primary
care consultations
—
Comments — — — With inclusion of patients’ costs (travel and time),
societal costs of home and hospital cardiac
rehabilitation were not significantly different
NR=not reported; ECG=electrocardiography.
1.05 (0.98  to 1.14)
0.83 (0.68 to 1.00)
1.08 (0.89 to 1.31)
0.93 (0.62 to 1.41)
1.04 (0.88 to 1.22)
1.14 (0.96 to 1.35)
1.01 (0.95 to 1.07)
0.00 (0.00 to 0.00)
0.94 (0.83 to 1.06)
1.07 (0.91 to 1.26)
0.91 (0.73 to 1.14)
0.90 (0.69 to 1.18)
0.00 (0.00 to 0.00)
1.00 (0.97 to 1.04)
17.0
5.8
6.2
1.8
4.7
4.7
37.2
0.0
12.4
4.2
4.3
1.7
0.0
100.0
0.5 0.7 1 1.5 2
Favours centre
based CR
Favours home
based CR
Risk ratio
(fixed 95% CI)
Risk ratio
(fixed 95% CI)
Weight
(%)
113/120
32/42
50/60
11/15
45/49
52/54
239/263
60/60
74/90
28/30
26/33
9/10
18/18
757/844
Favours home
based CR
109/122
35/38
34/44
11/14
23/26
22/26
236/262
65/65
79/90
27/31
26/30
10/10
18/18
695/776
Favours centre
based CR
  Arthur 200236
  Carlson 200032
  Dalal 200721
  Daskapan 200534
  Gordon 2002 (community)26
  Gordon 2002 (supervised)26
  Jolly 200722
  Kassaian 200025
  Marchionni 200324
  Miller 1984 (brief)27
  Miller 1984 (expanded)27
  Sparks 199337
  Wu 200635
Total (95% CI)
Test for heterogeneity: χ2=11.44, df=10, P=0.32, I2=13%
Test for overall effect: z=0.21, P=0.83
Fig 11 | Number of participants with outcome data at follow-up (completers)
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the hypothesis that patients who can choose a pro-
gramme to suit their lifestyle and preferences will
have a higher rate of adherence and improved out-
comes. Superior rates of adherence to home based
rehabilitation, however, have been reported,19 and
offering patients a choice of rehabilitation could
improve the current low uptake,40 especially in older
patients, the socially deprived, ethnic minorities, and
those from rural areas who might have practical pro-
blems in accessing centre based facilities, in whom
poor rates of uptake and adherence have been
reported.41
Small differences in the costs of cardiac rehabilita-
tion were seen for the two trials based in the UK.31 42
The trial by Jolly et al (Birmingham rehabilitation
uptake maximisation (BRUM)) found that the home
based programme was more costly, possibly because
of the higher rate of home visiting undertaken in this
study compared with CHARMS.31 42 Relatively higher
costs were reported with intensive, highly monitored
cardiac rehabilitation programmes offered in North
America and western Europe.24 32 Current reimburse-
ment tariffs in the US require medical supervision, but
as only 10-20% of patients in the US receive cardiac
Table 9 | Summary of use of health care in home and centre based settings by months of follow-up
Variable
Dalal et al,21 2007,
Taylor et al,31 2007
(9 months)
Gordonet al,26 2002
(3 months
Bell et al,30 1998
Carlson et al,32
2000 (6 months
Marchionni et al,24
2003
(14 months)
Jolly et al,22 2007
0-6 months 6-12 months 12 months 24 months
No (%) of patients readmitted to hospital:
Time (months): — — — — — — 6-12 12-24
Home 9/60 (15) — 21/90 (23) 13/89 (15) — — — —
Hospital 6/44 (14) — 19/88 (22) 12/84 (14) — — — —
P value 0.84 — 0.78* 0.95* — — — —
Mean (SD) No of readmissions:
Home 2.2 (0.9)† — — — — 0.46 (SE 0.1) 0.08 (0.34) 0.20 (0.45)
Hospital 1.2 (0.6) — — — — 0.33 (SE 0.1) 0.12 (0.41) 0.26 (0.57)
P value 0.38 — — — — 0.49* 0.3 0.3
Mean (SD) No of primary care consultations:
Time period (months): 9-12 21-24
Home 6.3 (0.6) — 6.6 (3.6)‡ 5.4 (4.1) — — 0.65 (1.14) 0.53 (1.14)
Hospital 7.0 (0.9) — 6.6 (4.1) 4.6 (3.7) — — — 0.66 (1.42)
P value 0.514 — 1.00* 0.19* — — — —
No (%) of patients taking secondary prevention medication:
β blockers:
Home 31/49 (63) 36/97 (37) — — 19/38 — 169 (72.2) 161 (71.6)
Hospital 24/34 (71) 17/45 (38) — — 18/42 — 171 (73.4) 164 (72.2)
P value 0.49 NS — — 0.52* — 0.8 0.9
ACE inhibitors:
Home 30/49 (61) 25/97 (26)§ — — 4/38 — 176 (75.2)§ 177 (78.7)§
Hospital 24/33 (73) 8/45 (18) — — 4/42 — 161 (69.1)§ 156 (68.7)§
P value 0.28 NS — — 0.88* — 0.1 0.02
Antihypertensives:
Home 73/97 (75) — — 5/38 — — —
Hospital 33/45 (73) — — 8/42 — — —
P value NS — — 0.47* — — —
Statins
Home 48/49 (98) — — — 15/38 — 216 (92.3)** 195 (86.7)**
Hospital 30/35 (88) — — — 20/42 — 221 (94.8)** 206 (90.7)**
P value 0.18* — — — 0.54* — 0.3 0.2
Antiplatelets:
Home 46/49 (94) 94/97 (97)¶ — — — — 227 (97.0)†† 214 (95.1)††
Hospital 30/35 (86) 45/45 (100)¶ — — — — 226 (97.0)†† 220 (96.9)††
P value 0.21 NS* — — — — 1.0 0.3
NS=not significant.
*Calculated by authors of present report.
†Number of nights.
‡GP consultation.
§Angiotensin converting enzyme (ACE) inhibitor or angiotensin II receptor antagonist.
¶Antiplatelets and anticoagulants.
**Cholesterol lowering drug.
††Aspirin or antiplatelet drug.
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rehabilitation aftermyocardial infarction and coronary
revascularisation, there is a case to be made for widen-
ing access.10
Implications for practice
Homebased and hospital or centre based cardiac reha-
bilitation seem to be equally effective in improving
clinical outcomes and health related quality of life out-
comes in low risk patients after acute myocardial
infarction and revascularisation. This finding, together
with an absence of evidence of differences in health-
care costs between the two approaches, supports the
further provision of evidence based, home based car-
diac rehabilitation programmes such as the Heart
Manual. The choice of participating in a more tradi-
tional supervised centre based or home based pro-
gramme should reflect the preference of the
individual patient.
Implications for research
Data are needed to determine whether the effects of
home based and centre based cardiac rehabilitation
reported in short term trials can be confirmed in the
longer term. Comparative trials are needed to assess
the relative impact of supervised centre based and
home based cardiac rehabilitation in patients with
heart failure. Such studies need to consider economic
factors and patient related outcomes, including costs to
the healthcare system and health related quality of life.
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